US Patent Issued to Providence Health & Services-Oregon, Oregon Health & Science University on June 24 for "Cancer therapeutic compositions and methods targeting DNAse1L3" (Oregon Inventors)

ALEXANDRIA, Va., June 25 -- United States Patent no. 12,336,973, issued on June 24, was assigned to Providence Health & Services-Oregon (Portland, Ore.) and Oregon Health & Science University (Portland, Ore.).

"Cancer therapeutic compositions and methods targeting DNAse1L3" was invented by Michael Gough (Portland, Ore.), Marka Crittenden (Portland, Ore.) and Tiffany Blair (Portland, Ore.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for treating a subject with cancer, including administering to the subject an effective amount of an inhibitor of DNAse1L3 and an effective amount of radiation therapy are provided. In some examples, the methods involve enhancing or inducing response of tumor-associated ...